Oct 23, 2026 07:20PM
Oct 2, 2026 10:00AM
Oct 2, 2026 10:00AM
Sep 23, 2026 07:00AM
Sep 23, 2026 07:00AM
Sep 21, 2026 04:05PM
Sep 21, 2026 04:05PM Travere Therapeutics Announces Planned Chief Executive Officer Transition
Aug 4, 2026 04:01PM
Jun 25, 2026 07:40AM
Jun 16, 2026 04:30PM
Jun 16, 2026 04:30PM
Jun 4, 2026 10:09AM
Jun 4, 2026 10:09AM
Jun 2, 2026 07:01AM Travere licenses BTK inhibitor from Everest for rare kidney diseases
Jun 2, 2026 07:01AM
May 27, 2026 04:05PM
May 27, 2026 04:05PM
May 4, 2026 04:01PM
Apr 24, 2026 06:45AM
Apr 14, 2026 07:08AM
Apr 14, 2026 07:00AM FDA approves FILSPARI for rare kidney disease FSGS
Apr 14, 2026 07:00AM
Apr 14, 2026 06:47AM
Apr 13, 2026 06:16PM
Apr 13, 2026 06:16PM
Feb 19, 2026 04:01PM
Jan 16, 2026 01:20PM
Jan 14, 2026 06:48AM Guggenheim Reiterates Buy rating and Best Idea on Travere Therapeutics (TVTX)
Jan 13, 2026 01:24PM
Jan 13, 2026 01:24PM
Jan 13, 2026 07:27AM
Jan 13, 2026 04:57AM
Jan 12, 2026 05:00PM
Jan 12, 2026 05:00PM
Dec 24, 2025 11:54AM FDA;s messaging is positive for Travere Therapeutics (TVTX) - Cantor Fitzgerald
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Oct 30, 2025 04:01PM
Oct 17, 2025 09:01AM
Sep 26, 2025 07:02AM
Sep 26, 2025 07:00AM
Sep 11, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Sep 10, 2025 10:30AM
Sep 10, 2025 10:11AM
Sep 10, 2025 09:58AM
Sep 10, 2025 07:01AM
Sep 10, 2025 07:01AM
Sep 3, 2025 07:01AM
Aug 28, 2025 07:33AM Travere Therapeutics (TVTX) PT Raised to $47 at H.C. Wainwright
Aug 27, 2025 05:09PM

335,221 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All